Popular Articles

Blogs Comment On Supreme Court Decisions, Obama Administration, Other Topics
The following summarizes selected women"s health-related blog entries. ~ "Just Released: Gains and Losses for Women in 2008-09 Supreme Court Decisions," National Women"s Law Center"s "Womenstake": The Supreme Court"s 2008-2009 term, which concluded Monday, included "several crucial decisions that demonstrate the impact of the court on women"s lives," according to the blog post, which summarizes a new analysis from NWLC on the cases. For example, the blog post says that the rulings in Fitzgerald v. Barnstable School Committee and Crawford v. Metropolitan Government of Nashville and Davidson County, Tenn., increased employees" protections against discrimination in the workplace. However, the rulings in Ricci v. DeStetano -- which overturned an appellate court"s anti-discrimination ruling -- and AT&T Corp. v. Hulteen -- which "permitted AT&T to pay women lower pension benefits for the rest of their lives" -- were "not as positive," the blog entry says. NWLC Co-President Marcia Greenberger said that the Supreme Court "ignored the realities of the workplace and the intent of Congress and ruled against female workers" in AT&T v. Hulteen. Greenberger also said that such cases "underscore why every seat on the Supreme Court is of paramount importance to women," adding that it is "absolutely critical" that Supreme Court nominees have "a strong commitment to upholding and enforcing women"s basic legal rights and protections" ("Womenstake," National Women"s Law Center, 6/29).~ "Waldman and Saletan: Oh What a Fine Bromance!" Jodi Jacobson, RH Reality Check: In a recent bloggingheads.tv chat on "common ground" in the abortion-rights debate, Slate columnist Will Saletan and Beliefnet Editor-in-Chief Steve Waldman "spent as much time as possible complimenting each other"s work" and "as little as possible on any real substance regarding reproductive health and choice issues," Jacobson writes. It is "clear that the Obama administration"s stated intention to create "a common ground platform"" on abortion rights has become "a full employment program for both Waldman and Saletan," she writes. Jacobson continues, "So perhaps the most striking thing about the conversation was that, in the end, they both effectively concluded that the common ground enterprise was a "just for show" political strategy," and that the "real strategies" necessary to reduce the need for abortion "are the very prevention programs least likely to be supported by the far right. (Revelation!)." She adds, "However, they came to this conclusion through the same faux-expert uninformed arguments that characterize their columns." During the "Will-interviews-Steve format," Saletan "revealed once again that there is no core philosophy or framework underlying his ever-shifting positions on choice and abortion," according to Jacobson. She adds that "Waldman, for his part, several times underscored what is clear from reading his work": that he "just throws things "out there" without considered thought" about what "might be good versus bad data, not understanding how to read evidence," and "oblivious or uncaring about the effects his free-form moralistic misinformation and opinions might actually have on an already polarized debate." According to Jacobson, "Public policies affecting sexual and reproductive health issues" should be "based first and foremost on public health and on promoting individual rights balanced by individual responsibilities," but "as anyone living on Planet Earth knows, sex and reproduction have become the front in a war waged by ultra-conservative religious and political forces for which Waldman serves as a paid flacky." She continues, "In fact, Waldman himself stated during the program: "I have a corporate interest in injecting religion into every debate."" Jacobson states, "Reading and watching this duo is like buying the OK! magazine version of the culture wars at the grocery store; they put whatever sells on the front cover, no matter the truth or consequences.
new payday loan lenders
Important Therapeutic Target For Breast Cancer: Newly Appreciated Membrane Estrogen Receptor
New research at Rhode Island Hospital has uncovered the biological effects of a novel membrane estrogen receptor, a finding that has potential implications for hormonal therapy for breast cancer. The study is published in the July edition of the journal Molecular Endocrinology. This new study by Edward Filardo, MD, and his research team further supports earlier published work by the group that linked the transmembrane receptor, GPR30/GPER-1, to specific estrogen binding, rapid estrogen signaling and breast cancer metastasis. "What is exciting about this new work," says Filardo, "is that it provides some insight into the influence of GPR30 at the cellular level. It shows that estrogen action through GPR30 allows for breast tumor cell survival, and not breast tumor cell proliferation." Prior studies by Filardo"s group showed that estrogen acts through GPR30 to promote the rapid release of preformed growth factors that are tethered to the surface of breast cancer cells. Their latest study was conducted in an effort to better understand the mechanism by which GPR30 triggered the release of epidermal growth factor (EGF) polypeptides from the surface of breast cancer cells.
News of the day
Costly Drugs Known As Biologics Prompt Exclusivity Debate
"A bitter Congressional fight over the cost of superexpensive biotechnology drugs has come down to a single, hotly debated number: How many years should makers of those drugs be exempt from generic competition?" The New York Times reports. "At issue are such drugs as Biogen Idec"s Avonex, for multiple sclerosis, which can cost more than $20,000 a year; Genentech"s Avastin for cancer, which can cost more than $50,000; and several Genzyme drugs for rare diseases that can cost $200,000 a year or more. ò€¦ Because they are hard to copy exactly, they have not been subject to the generic competition that eventually knocks down the price of drugs like Lipitor and Prozac."
Oncology

Canada Sees Spread Of Lyme Disease: Physicians Crucial In Helping Minimize Its Impact

Lyme disease is emerging in Canada, and is expected to increase with climate change, but effective, enhanced surveillance and clinician awareness will be key to minimizing the impact of the disease, write researchers in a review in CMAJ (Canadian Medical Association Journal). Lyme disease is transmitted by ticks which feed on animal or human hosts. It begins with a skin lesion that expands and if untreated, can result in facial palsy, meningitis, cardiac issues and progress to nerve damage (peripheral neuropathy) and inflammation of the brain and spinal cord (encephalomyelitis). Epidemiological understanding about a patient"s likely exposure to ticks is key, as serological testing is insensitive in the early stages of disease but can be useful in the later stages. Current passive surveillance for ticks has identified new endemic areas in Canada but additional methods are needed to identify emerging areas of Lyme disease. Populations of the tick (Ixodes scapularis) are emerging in southern Ontario, Nova Scotia, southeastern Manitoba, New Brunswick and southern Quebec. Tick populations (I. pacificus) are widespread in southern British Columbia, although the prevalence of the Lyme disease agent (Borrelia burgdorferi) in those populations is lower than in the tick spreading in the east. Vigilance by clinicians will help in disease surveillance and in prompt treatment. An important role of surveillance will be to inform the public and physicians about local risks and what to do for prevention and early diagnosis of Lyme disease. "Lyme disease is emerging in Canada, and effective, enhanced surveillance needs to be instigated, and physician awareness of Lyme disease will be crucial to minimizing the impact of the disease," write Dr. Nicholas Ogden from the Public Health Agency of Canada and coauthors. Kim Barnhardt Canadian Medical Association Journal


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):